Send Inquiry

Request To Call Back

KERENDIA FINERENONE TABLETS

Get a Price/Quote

MOQ : 100 Boxes

KERENDIA FINERENONE TABLETS Specification

Origin of Medicine
India

Indication
Used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease associated with Type 2 Diabetes

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
30 tablets per box

Salt Composition
Finerenone

Drug Type
Allopathic

Ingredients
Finerenone

Physical Form
Tablets

Function
Nonsteroidal mineralocorticoid receptor antagonist

Recommended For
Chronic Kidney Disease (CKD) in adults with Type 2 Diabetes

Dosage
10 mg or 20 mg once daily, as prescribed by physician

Dosage Guidelines
As Per Suggestion

Suitable For
Adults

Quantity
As required

Storage Instructions
Cool & Dry Place

Route of Administration
Oral

Pack Type
Strip/Box

Strength
10 mg, 20 mg

Shelf Life
24 months from the date of manufacture

Color
Film-coated, yellow tablets

Prescription/Non prescription
Prescription

Side Effects
Possible side effects include hyperkalemia, hypotension, hyponatremia, dizziness

Warning & Precautions
Not recommended during pregnancy or breastfeeding; monitor potassium levels

KERENDIA FINERENONE TABLETS Trade Information

Minimum Order Quantity
100 Boxes

Supply Ability
5000 Boxes Per Month

Delivery Time
7 Days

Packaging Details
PACK OF 14 TABLETS.

Main Domestic Market
All India

About KERENDIA FINERENONE TABLETS

Description:-

Brand Name : Kerendia

Content : Finerenone Film Coated

Strength: Finerenone Film Coated 10mg

Packing : 14 Tablets

Type : Tablets

Manufactured by: Bayer Zydus...............

How KERENDIA Finerenone Tablets Work

KERENDIA acts as a nonsteroidal mineralocorticoid receptor antagonist, helping to lower excess mineralocorticoid activity in patients with chronic kidney disease related to Type 2 Diabetes. By mitigating this effect, KERENDIA can reduce risks of kidney function decline and cardiovascular complications.

Recommended Usage and Dosage

KERENDIA should be taken orally, once daily in strengths of 10 mg or 20 mg, according to the doctors prescription. Dosage may vary based on clinical evaluation and potassium levels, so ongoing monitoring is necessary for optimal safety and efficacy.

FAQs of KERENDIA FINERENONE TABLETS:

Q: How should KERENDIA Finerenone Tablets be taken for best results?

A: Take KERENDIA orally once per day at the prescribed dose of 10 mg or 20 mg. Always follow your physicians dosage instructions and do not adjust your dose independently.

Q: What are the main benefits of using KERENDIA for CKD in adults with Type 2 Diabetes?

A: KERENDIA provides significant benefit by reducing the risk of sustained reduction in kidney function, progression to end-stage kidney disease, cardiovascular death, nonfatal heart attacks, and hospitalization for heart failure.

Q: When should KERENDIA not be used or taken with caution?

A: This medicine is not recommended during pregnancy or breastfeeding and must be used with caution in patients with high potassium levels. Regular monitoring of potassium is advised while using KERENDIA.

Q: Where should KERENDIA tablets be stored to maintain their efficacy?

A: Always store KERENDIA tablets in a cool, dry place, away from moisture and heat. Ensure that they are kept in their original packaging until use and do not use them past their shelf life (24 months from manufacture).

Q: What side effects can occur while taking KERENDIA Finerenone Tablets?

A: Possible side effects include hyperkalemia (high potassium), hypotension (low blood pressure), hyponatremia (low sodium), and dizziness. These effects should be closely monitored by a healthcare provider.

Q: Who is KERENDIA suitable for and what is its primary indication?

A: KERENDIA is suitable for adult patients diagnosed with chronic kidney disease associated with Type 2 Diabetes. Its main indication is to reduce the risk of progression to kidney failure and major cardiovascular events.

Tell us about your requirement